Atomistry » Chlorine » PDB 1wbo-1wve » 1wut
Atomistry »
  Chlorine »
    PDB 1wbo-1wve »
      1wut »

Chlorine in PDB 1wut: Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes

Enzymatic activity of Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes

All present enzymatic activity of Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes:
2.4.1.1;

Protein crystallography data

The structure of Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes, PDB code: 1wut was solved by T.Klabunde, K.U.Wendt, D.Kadereit, V.Brachvogel, H.-J.Burger, A.W.Herling, N.G.Oikonomakos, M.N.Kosmopoulou, D.Schmoll, E.Sarubbi, E.Von Roedern, K.Schonafinger, E.Defossa, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.49 / 2.26
Space group P 43 21 2
Cell size a, b, c (Å), α, β, γ (°) 128.679, 128.679, 115.977, 90.00, 90.00, 90.00
R / Rfree (%) 20.1 / 23.6

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes (pdb code 1wut). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes, PDB code: 1wut:
Jump to Chlorine binding site number: 1; 2; 3;

Chlorine binding site 1 out of 3 in 1wut

Go back to Chlorine Binding Sites List in 1wut
Chlorine binding site 1 out of 3 in the Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl930

b:35.1
occ:1.00
CL1 A:BN2930 0.0 35.1 1.0
C1 A:BN2930 1.7 34.9 1.0
C2 A:BN2930 2.7 32.5 1.0
C6 A:BN2930 2.7 34.6 1.0
C7 A:BN2930 3.1 34.4 1.0
O1 A:BN2930 3.1 37.5 1.0
CD1 A:TRP67 3.3 20.4 1.0
CG A:TRP67 3.4 20.8 1.0
CG A:GLN71 3.5 30.6 1.0
NE1 A:TRP67 3.6 20.7 1.0
O A:TRP67 3.6 21.4 1.0
CD2 A:TRP67 3.6 20.3 1.0
CE2 A:TRP67 3.7 19.8 1.0
C A:TRP67 3.7 22.5 1.0
CB A:TRP67 3.9 21.5 1.0
N A:ILE68 4.0 22.8 1.0
O A:HOH1194 4.1 31.8 1.0
C3 A:BN2930 4.1 32.5 1.0
C5 A:BN2930 4.1 32.4 1.0
N1 A:BN2930 4.1 36.0 1.0
O A:HOH1213 4.2 45.1 1.0
CA A:ILE68 4.2 22.7 1.0
CB A:GLN71 4.2 29.9 1.0
CE3 A:TRP67 4.4 19.9 1.0
CA A:TRP67 4.4 22.3 1.0
CZ2 A:TRP67 4.6 19.6 1.0
C4 A:BN2930 4.6 31.9 1.0
CG1 A:ILE68 4.7 21.0 1.0
CD A:GLN71 4.7 31.1 1.0
OG1 A:THR240 4.9 20.1 1.0

Chlorine binding site 2 out of 3 in 1wut

Go back to Chlorine Binding Sites List in 1wut
Chlorine binding site 2 out of 3 in the Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl930

b:45.2
occ:1.00
CL2 A:BN2930 0.0 45.2 1.0
C11 A:BN2930 1.7 44.5 1.0
C10 A:BN2930 2.6 43.0 1.0
C12 A:BN2930 2.8 46.0 1.0
O3 A:BN2930 3.1 43.8 1.0
C15 A:BN2930 3.3 49.6 1.0
OE1 A:GLN72 3.8 51.7 1.0
C9 A:BN2930 4.0 41.3 1.0
C13 A:BN2930 4.0 44.8 1.0
C14 A:BN2930 4.5 43.3 1.0
CD A:GLN72 4.6 49.6 1.0
CB A:GLN72 4.6 40.1 1.0
C16 A:BN2930 4.8 53.3 1.0

Chlorine binding site 3 out of 3 in 1wut

Go back to Chlorine Binding Sites List in 1wut
Chlorine binding site 3 out of 3 in the Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 3 of Acyl Ureas As Human Liver Glycogen Phosphorylase Inhibitors For the Treatment of Type 2 Diabetes within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl930

b:49.7
occ:1.00
CL3 A:BN2930 0.0 49.7 1.0
C13 A:BN2930 1.7 44.8 1.0
C14 A:BN2930 2.6 43.3 1.0
C12 A:BN2930 2.7 46.0 1.0
CB A:TYR75 3.0 41.8 1.0
O3 A:BN2930 3.0 43.8 1.0
CG A:TYR75 3.2 43.4 1.0
CD2 A:TYR75 3.6 44.4 1.0
CA A:GLN72 3.8 37.3 1.0
C15 A:BN2930 3.8 49.6 1.0
CD1 A:TYR75 3.9 44.6 1.0
C16 A:BN2930 3.9 53.3 1.0
C9 A:BN2930 4.0 41.3 1.0
C11 A:BN2930 4.0 44.5 1.0
O A:GLN71 4.1 33.8 1.0
O A:GLN72 4.3 35.7 1.0
CA A:TYR75 4.4 40.2 1.0
C10 A:BN2930 4.5 43.0 1.0
N A:GLN72 4.5 35.2 1.0
CE2 A:TYR75 4.5 46.1 1.0
C A:GLN72 4.5 36.9 1.0
C A:GLN71 4.6 32.4 1.0
CB A:GLN72 4.6 40.1 1.0
CE1 A:TYR75 4.7 45.8 1.0
N A:TYR75 4.9 37.6 1.0
CZ A:TYR75 5.0 46.9 1.0

Reference:

N.G.Oikonomakos, M.N.Kosmopoulou, E.D.Chrysina, D.D.Leonidas, I.D.Kostas, K.U.Wendt, T.Klabunde, E.Defossa. Crystallographic Studies on Acyl Ureas, A New Class of Glycogen Phosphorylase Inhibitors, As Potential Antidiabetic Drugs Protein Sci. V. 14 1760 2005.
ISSN: ISSN 0961-8368
PubMed: 15987904
DOI: 10.1110/PS.051432405
Page generated: Sat Dec 12 08:54:04 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy